Literature DB >> 35153154

Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?

Amit Roy1, Olga Green1, Randall Brenneman1, Walter Bosch1, Hiram A Gay1, Jeff M Michalski1, Brian C Baumann2.   

Abstract

BACKGROUND: We evaluated inter-fraction penile bulb (PB) changes in prostate cancer (PCa) patients undergoing MR-guided RT in the post-radical prostatectomy (RP) setting.
MATERIALS AND METHODS: 10 patients with PCa status-post RP received MR-guided RT from 2017-2019. Patients received daily setup volumetric MRI scans prior to RT delivery for alignment and target localization. Setup MRI datasets from Fx 1, Fx 19, and Fx 37 were fused for each patient based on soft tissue anatomy. The PB was contoured on each MRI. Data on volume (cc), superior/inferior positional change (cm), and mean dose (Gy) was collected. Differences were assessed by Student's t-test (sig. p<0.05).
RESULTS: The mean PB volume change from Fx 1→ 19 was +0.34 ± 0.34 cc (p=0.11) and from Fx 1→ 37 was +0.22 ± 0.28 cc (p=0.31). The mean positional change from Fx 1→ 19 was +0.08±0.26 cm (p=0.37) and from Fx 1→ 37 was +0.05 ±0.25 cm (p=0.57). The mean change in mean PB dose from Fx 1→ 19 was +0.19±4.86 Gy (p=0.98) and from Fx 1→ 37 was -1.51≖7.46 Gy (p=0.88).
CONCLUSION: We present the first study evaluating inter-fraction changes to the PB during MR-guided RT. We found no clinically meaningful difference in the volume, positional change, or mean dose during RT in the post-prostatectomy setting, suggesting that PB organ motion may not need to be accounted for in radiation treatment planning.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRI-guided radiotherapy; Organ motion; Penile bulb; Prostate-bed radiotherapy; Sexual toxicity

Mesh:

Year:  2022        PMID: 35153154      PMCID: PMC9169576          DOI: 10.1016/j.clgc.2022.01.006

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   3.121


  41 in total

1.  High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.

Authors:  Piet Ost; Nicolaas Lumen; An-Sofie Goessaert; Valérie Fonteyne; Bart De Troyer; Filip Jacobs; Gert De Meerleer
Journal:  Eur Urol       Date:  2011-04-16       Impact factor: 20.096

2.  Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

Authors:  Mack Roach; Kathryn Winter; Jeffrey M Michalski; James D Cox; James A Purdy; Walter Bosch; Xiao Lin; William S Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

3.  Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.

Authors:  A Gabriella Wernicke; Richard Valicenti; Kelly Dieva; Christopher Houser; Ed Pequignot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

4.  Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.

Authors:  L E Henke; J A Contreras; O L Green; B Cai; H Kim; M C Roach; J R Olsen; B Fischer-Valuck; D F Mullen; R Kashani; M A Thomas; J Huang; I Zoberi; D Yang; V Rodriguez; J D Bradley; C G Robinson; P Parikh; S Mutic; J Michalski
Journal:  Clin Oncol (R Coll Radiol)       Date:  2018-09-07       Impact factor: 4.126

Review 5.  Radiation dose-volume effects and the penile bulb.

Authors:  Mack Roach; Jiho Nam; Giovanna Gagliardi; Issam El Naqa; Joseph O Deasy; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

6.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  Pract Radiat Oncol       Date:  2018-10-11

7.  Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.

Authors:  Christopher J D Wallis; Zhiguo Zhao; Li-Ching Huang; David F Penson; Tatsuki Koyama; Sherrie H Kaplan; Sheldon Greenfield; Amy N Luckenbaugh; Zachary Klaassen; Ralph Conwill; Michael Goodman; Ann S Hamilton; Xiao-Cheng Wu; Lisa E Paddock; Antoinette Stroup; Matthew R Cooperberg; Mia Hashibe; Brock B O'Neil; Karen E Hoffman; Daniel A Barocas
Journal:  JAMA Oncol       Date:  2022-01-01       Impact factor: 31.777

8.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

9.  Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.

Authors:  Ugur Selek; Rex Cheung; Mingfwu Lii; Pamela Allen; Roy E Steadham; Terry R Vantreese; Darren J Little; Isaac I Rosen; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

Review 10.  ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2017-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.